DKSH aims to be or remain among the best in the world in all dimensions of business excellence. Year after year, we are awarded for our attractiveness as an employer and for achievements in our areas of work.
DKSH has announced the acquisition of Swiss Refarmed Group today. With this transaction, DKSH Performance Materials significantly expands its capabilities in Active Pharmaceutical Ingredients (APIs) and strengthens its position as a leading Life Sciences distributor.
DKSH Business Unit Healthcare has signed an agreement to acquire Acutest Systems, a Malaysian in-vitro diagnostic provider. The transaction is in line with DKSH's strategy of further expanding in the fragmented medical devices industry in Asia Pacific.
DKSH has joined the United Nations Global Compact initiative, the largest corporate responsibility initiative in the world, further strengthening its commitment to sustainability.